恩杂鲁胺专利技术综述

Patent Analysis for Enzalutamide

恩杂鲁胺是新型抗前列腺癌治疗药物,用于治疗去势抵抗性前列腺癌(CRPC)。本文从专利申请趋势、地区分布、重要申请人角度对恩杂鲁胺相关专利申请情况进行统计分析,围绕恩杂鲁胺相关专利技术以及原研公司的重点专利进行分析,对国内仿制药企业的后期开发提供参考。

Enzalutamide is a new anti-prostate cancer drug,specifically for the treatment of castration-resistant prostate cancer(CRPC).This paper makes a statistical analysis of the patent applications related to enzalutamide from the perspective of the trend of patent applications,regional distribution and important applicants,and analyzes the patent technologies and the important patents of enzalutamide from the original company,to provide a reference for the domestic pharmaceutical enterprises with the development in this area.